ARTICLE AD BOX
Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers have uncovered a key genetic factor that worsens the condition. Even more surprising, the most effective way to target this factor may be an already approved and widely available treatment: vitamin B3.
An international research team led by Professor Jang Hyun Choi at UNIST, working with Professor Hwayoung Y...

5 days ago
11








English (US) ·